Nancy J Vance, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 225, Crestview Hills, KY 41017 Phone: 859-341-5400 Fax: 859-578-4594 |
Charles Jeffrey Burgher, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 334 Thomas More Pkwy, Crestview Hills, KY 41017 Phone: 859-578-3400 Fax: 859-957-0055 |
Michelle Voet, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 225, Crestview Hills, KY 41017 Phone: 859-341-5400 Fax: 859-578-4594 |
News Archive
The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.
Tarsa Therapeutics, Inc. today announced completion of its global Phase III ORACAL trial testing the company's once-daily oral recombinant calcitonin for the treatment of postmenopausal osteoporosis. Results from the ORACAL trial are expected in early spring. In addition, Tarsa announced initiation of a new Phase II study of its oral calcitonin for the prevention of postmenopausal osteoporosis.
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Despite decades of advances in diabetes care, African Americans and Latinos are still far less likely than whites to have their blood sugar under control, even with the help of medications, a new nationally representative study finds.
A large study of psychiatric inpatients supports the notion that electrodermal hyporeactivity may be an accurate marker of suicide risk.
› Verified 8 days ago